Unicycive Therapeutics, Inc. (UNCY)

Unicycive Therapeutics Statistics

Total Valuation

UNCY has a market cap or net worth of $55.87 million. The enterprise value is $40.32 million.

Market Cap	55.87M
Enterprise Value	40.32M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

UNCY has 12.64 million shares outstanding. The number of shares has increased by 196.89% in one year.

Current Share Class	12.64M
Shares Outstanding	12.64M
Shares Change (YoY)	+196.89%
Shares Change (QoQ)	+17.14%
Owned by Insiders (%)	4.98%
Owned by Institutions (%)	16.49%
Float	7.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	22.06
PS Ratio	n/a
Forward PS	n/a
PB Ratio	5.00
P/TBV Ratio	5.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.05.

Current Ratio	1.64
Quick Ratio	1.19
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-468.21

Financial Efficiency

Return on equity (ROE) is -92.09% and return on invested capital (ROIC) is -112.73%.

Return on Equity (ROE)	-92.09%
Return on Assets (ROA)	-48.08%
Return on Invested Capital (ROIC)	-112.73%
Return on Capital Employed (ROCE)	-274.17%
Revenue Per Employee	n/a
Profits Per Employee	-$701,870
Employee Count	23
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.41% in the last 52 weeks. The beta is 1.89, so UNCY's price volatility has been higher than the market average.

Beta (5Y)	1.89
52-Week Price Change	-2.41%
50-Day Moving Average	5.80
200-Day Moving Average	5.88
Relative Strength Index (RSI)	40.71
Average Volume (20 Days)	637,997

Short Selling Information

The latest short interest is 1.42 million, so 11.24% of the outstanding shares have been sold short.

Short Interest	1.42M
Short Previous Month	796,858
Short % of Shares Out	11.24%
Short % of Float	18.13%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.90M
Pretax Income	-36.93M
Net Income	-16.14M
EBITDA	-30.88M
EBIT	-30.90M
Earnings Per Share (EPS)	-$2.60

Balance Sheet

The company has $19.77 million in cash and $548,000 in debt, giving a net cash position of $19.22 million or $1.52 per share.

Cash & Cash Equivalents	19.77M
Total Debt	548,000
Net Cash	19.22M
Net Cash Per Share	$1.52
Equity (Book Value)	11.27M
Book Value Per Share	0.94
Working Capital	10.67M

Cash Flow

In the last 12 months, operating cash flow was -$31.02 million and capital expenditures -$82,000, giving a free cash flow of -$31.10 million.

Operating Cash Flow	-31.02M
Capital Expenditures	-82,000
Free Cash Flow	-31.10M
FCF Per Share	-$2.46

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UNCY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-196.89%
Shareholder Yield	-196.89%
Earnings Yield	-27.11%
FCF Yield	-52.24%

Analyst Forecast

The average price target for UNCY is $63.75, which is 1,342.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$63.75
Price Target Difference	1,342.31%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 20, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Jun 20, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a